Paraganglioma of the head and neck region, treated with radiation therapy, a Rare Cancer Network study

Head & Neck ◽  
2019 ◽  
Vol 41 (6) ◽  
pp. 1770-1776 ◽  
Author(s):  
Yasmin Lassen‐Ramshad ◽  
Enis Ozyar ◽  
Senem Alanyali ◽  
Philip Poortmans ◽  
Paul Houtte ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Head And Neck ◽  
Neck Region ◽  
Rare Cancer ◽  
Head And Neck Region ◽  
Cancer Network

Late effects of radiation therapy in the head and neck region

1995 ◽  
Vol 31 (5) ◽  
pp. 1141-1164 ◽  
Author(s):  
Jay S. Cooper ◽  
Karen Fu ◽  
James Marks ◽  
Sol Silverman
Keyword(s):  
Radiation Therapy ◽  
Head And Neck ◽  
Late Effects ◽  
Neck Region ◽  
Head And Neck Region ◽  
Effects Of Radiation

scholarly journals Combined Bleomycin Treatment and Radiation Therapy in Squamous Cell Carcinoma of the Head and Neck Region

1985 ◽  
Vol 24 (6) ◽  
pp. 487-489 ◽  
Author(s):  
L.-M. Parvinen ◽  
M. Parvinen ◽  
E. Nordman ◽  
A. E. Kortekangas
Keyword(s):  
Squamous Cell Carcinoma ◽  
Radiation Therapy ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Region ◽  
Head And Neck Region

scholarly journals Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region

2020 ◽  
Author(s):  
Francesca De Felice ◽  
Daniela Musio ◽  
Vincenzo Tombolini
Keyword(s):  
Squamous Cell Carcinoma ◽  
Radiation Therapy ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Region ◽  
Cutaneous Squamous Cell Carcinoma ◽  
Head And Neck Region ◽  
Hypofractionated Radiation Therapy ◽  
Hypofractionated Radiation

Abstract Introduction Treatment of inoperable cutaneous squamous cell carcinoma (cSCC) of the head and neck region is still debated. Case report We report an original case of cure of cSCC of the head and neck region with weekly hypofractionated radiation therapy with megavoltage electrons prescribed for locally advanced inoperable disease. Results Weekly hypofractionated radiotherapy assured complete regression and was well-tolerated. Conclusion The real efficacy of this treatment in the therapeutic arsenal remains to be defined. A clinical trial is ongoing to test the use of 8 weekly fractions of 8 Gy hypofractionated RT regimens in non-resectable cSCC cases.

scholarly journals Mucosal Melanomas of the Head and Neck: The Role of Postoperative Radiation Therapy

ISRN Oncology ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Kunal Saigal ◽  
Donald T. Weed ◽  
Isildinha M. Reis ◽  
Arnold M. Markoe ◽  
Aaron H. Wolfson ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Head And Neck ◽  
Neck Region ◽  
Distant Metastases ◽  
Postoperative Radiation ◽  
Postoperative Radiation Therapy ◽  
Head And Neck Region ◽  
Definitive Surgery ◽  
The University

Objectives. Mucosal melanomas are rarer than their cutaneous counterparts and are associated with a poorer prognosis. We report the clinical outcomes of patients with mucosal melanomas of the head and neck region generally treated with definitive surgery followed by postoperative radiation therapy (RT). Methods. We reviewed the records of 17 patients treated at the University of Miami in 1990–2007. Patients generally received conventionally fractionated RT regimens to the postoperative bed. Elective nodal RT was not routinely delivered. Eight patients received adjuvant chemotherapy or immunotherapy. Results. Median followup was 35.2 months (range 5–225). As the first site of failure: 3 patients recurred locally, 2 regionally and 2 distantly. All 3 patients who recurred locally had not received RT. Of the 5 locoregional recurrences, 4 were salvaged successfully with multimodality therapy with no evidence of disease at last followup. Overall survival was 64.7% at 2 years and 51.5% at 5 years. Conclusions. Patients with mucosal melanoma of the head and neck are best treated with surgery to achieve negative margins, followed by postoperative RT to optimize local control. Elective nodal irradiation may not be indicated in all cases, as regional failures were not predominant. Distant metastases were fewer when compared to historical data, potentially due to advancements in adjuvant therapies as well as aggressive multi-modality salvage at time of failure.

Sign in / Sign up

Export Citation Format

Share Document